Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...

In 1967, however, ACE ... these new enzyme inhibitors. However, our synthetic expertise was an invaluable tool in allowing us to compensate for our isolation/structure elucidation inexperience.

In addition to their capacity to lower systemic blood pressure, angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-II receptor blockers (ARBs) are thought to have specific ...